SlideShare una empresa de Scribd logo
1 de 56
ELEKTROFORESIS PROTEIN SERUM Siswanto armadi, dr, Sp.PK(K) / Nuzulul Quriyah, drD 6-16-2010 1 Tutor Imunologi
PENDAHULUAN 6-16-2010 2
Elektroforesis 6-16-2010 3 Teknik pemisahan komponen/molekul bermuatan berdasarkan perbedaan tingkat migrasinya dalam sebuah medan listrik  Tutor Imun by Nuzul Pergerakan pd elektroforesis dijelaskan dengan gaya Lorentz :          F = qE F adalah gaya Lorentz,  q adalah muatan yang dibawa oleh obyek,  E adalah medan listrik  Posisimolekul yang terseparasipada gel dideteksidenganpewarnaan, ataudilakukankuantifikasidengan densitometer
Tutor Imun PrinsipElektroforesis by Nuzul Muatan listrik molekul biologi (misal : protein) tergantung pd pH dan komposisi medium dimana molekul  biologi  tersebut  terlarut       bersifat amfoter  yaitu bisa bermuatan positif atau negatif  (bermuatan positif bila pH larutan lebih kecil daripada titik isoelektrik,  bermuatan negatif bila pH larutan lebih besar daripada titik isoelektrik)  Dalam suatu medan listrik, molekul  biologi  yang  bermuatan  positif  (kation) bermigrasi ke elektroda negatif (katoda) dan sebaliknya, yang bermuatan negatif (anion) bermigrasi ke elektroda positif (anoda) 6-16-2010 4
6-16-2010 5 Dengan elektroforesis, protein plasma dapat dipisahkan menjadi fraksi albumin serta α1, α2, β, dan γ-globulin  Protein dalam plasma memiliki konsentrasi sekitar 1 mmol/L  56% protein plasma merupakan fraksi albumin, 4% adalah α1-globulin, α2-globulin 10%, β-globulin 12%, dan 18% merupakan γ-globulin  Tutor Imun Protein by Nuzul
ELEKTROFORESIS PROTEIN 6-16-2010 6
Elektroforesis Protein 6-16-2010 Besarnya muatan Media penyangga Elektroendosmosis Suhu Ukuran molekul Kekuatan medan listrik Kekuatan ion dari bufer Kecepatan migrasi molekul   Tutor Imun by Nuzul Click to add Title 7
KomponenSistemElektroforesis 6-16-2010 8 Tutor Imun by Nuzul Power supply Sampel Bufer Media penyangga Power supply Wicks Pewarnaan Gambar 1. Komponensistemelektroforesis
Tutor Imun by Nuzul Yang sering dipakai : serum dan plasma Cairan tubuh lain yang juga bisa dipakai : urine, cairan serebrospinal, cairan dari pleura, perikardium, peritoneum, membran sinovial, dan air mata  Tidak ada persiapan khusus yang dilakukan pasien, tetapi keadaan puasa  lebih baik untuk menghindari hiperlipemia Sampel yang diperlukan antara 0,3-25 μl tergantung dari konsentrasi analit  dan jenis media penyangga yang digunakan Sampel diberi penanda warna untuk mengetahui kapan elektroforesis harus  dihentikan, pada bufer asam dipakai methylene green atau methylene blue,  sedangkan pada bufer basa dipakai bromphenol blue. SAMPEL 6-16-2010 9
BUFER  6-16-2010 10 Tutor Imun by Nuzul Menjaga agar pH tetapkonstan Mengalirkan (conduct) arus listrik
SyaratBufer 6-16-2010 11 1 bufer tidak boleh bereaksi dengan sampel krn interaksi antara bufer dan sampel dapat  mempengaruhi gerakan molekul Tutor Imun by Nuzul 3 kekuatan ion dari larutan bufer harus dipertimbangkan kekuatan ionik rendah menghasilkan kecepatan migrasi lebih besar 2 pH yang dipilih harus memberi muatan tapi tidak menyebabkan denaturasi protein dari molekul yang diperiksa (protein dipisahkan pada suasana basa, pH 8 – 9)       protein bermuatan negatif
MEDIA PENYANGGA 6-16-2010 12 Tutor Imun by Nuzul Agarose  Gel Poly- acrylamide  Gel Starch  Gel Cellulose  Acetate Kertas murah, tapi  menyerap banyak  protein   menghasilkan pita yang lebar, resolusinya  jelek, waktu pemisahannya lebih lama granula yang  mengandung  amilosa dan  amilopektin,  bila suspensinya  dilarutkan dan  dipanaskan akan terbentuk larutan jernih dan menjadi gel pd pendinginan sering dipakai, bebas dari ionizable groups    pada buffer basa atau netral tidak terlalu terpengaruh oleh endosmosis, resolusi lbh tajam, jernih lebih kuat daripada kertas, dg ukuran pori-pori homogen, pemisahan protein lebih cepat, absorpsi protein minimal        hasil pita lebih jelas dan  lebih tajam masih terbatas  hanya untuk  pemisahan  isoenzim  dari alkali  fosfatase
Endosmosis danWick Flow 6-16-2010 13 Tutor Imun by Nuzul Endosmosis (electroendosmosis)terjadiketika media penyangga jadi bermuatan negatif akibat adsorpsi ion hidroksil dari bufer        muatan negatif menarik muatan positif dari bufer.  Saat dialiri listrik ion positif bergerak ke arah katoda, sedang gerakan muatan negatif (misal : protein) ke arah anoda. Krn endosmosis      gerakan menjadi lebih lambat, tidak bergerak atau terdorong kearah katoda  Wick Flow gerakankeatasdarilarutanbufermelaluikeduatepimembran yang terendamuntukmenggantikankelembaban yang hilangakibatpemanasan. Aliraninimemperlambatgerakanmolekulpada media penyangga
Gambar 2. Endosmosis 6-16-2010 14 Tutor Imun by Nuzul
POWER SUPPLY 6-16-2010 15 Tutor Imun by Nuzul 0-500 volt  0-100 mA Jikaprosespemisahanbutuhwaktu lama, arus yang konstanlebihdianjurkanuntukmeminimalkankenaikansuhu Jika waktu 30  menit atau kurang, maka voltase dinaikkan
PEWARNAAN 6-16-2010 16 Ponceau         S Amido Black Oil Red O Coomassie  Brilliant Blue R 250 Tutor Imun by Nuzul Schiff’s
6-16-2010 17 PembacaanHasil Tutor Imun by Nuzul Ada 2 Cara Kuantitatif Mengukur intensitas warna pada tiap pita. Kualitatif Membandingkan garis-garis fraksi dengan pola elektroforesis standar yang telah diketahui Metode eluasi Pita dipotong-potong beberapa bagian, pewarna kemudian dieluasikan dalam suatu larutan, warna yang larut tersebut dihitung dengan fotometer Densitometri -Intensitas warna tiap pita diukur langsung pada medianya dalam suatu sistem optik yang mirip dengan fotometer.  -Jika medianya tidak transparan, maka harus dijernihkan lebih dulu
ELEKTROFORESIS PROTEIN DI LABORATORIUM PK RSUD DR SOETOMO 6-16-2010 18
SEBIA Hydragel Protein (E) K-20 6-16-2010 19 Tutor Imun by Nuzul Tabel 1. ReagendanBahandalam Kit Hydragel Protein (E) K20
Alat-Alat yang Dipakai 6-16-2010 20 Tutor Imun by Nuzul Gambar 3. Electrophoresis Chamber Gambar 5. Staining - Destaining solution Gambar 4. Agarose gel
Alat-Alat yang Dipakai 6-16-2010 21 Tutor Imun by Nuzul Gambar 6. Aplikator Gambar 7. Aplikatorcarrier Gambar 8. Microprocessor (power supply) Gambar 9. Inkubator
Alat-Alat yang Dipakai 6-16-2010 22 Tutor Imun by Nuzul Scanner λ 570 nm atau filter kuning
PROSEDUR SEBIA 6-16-2010 23
TahapMigrasi 6-16-2010 24 Tutor Imun by Nuzul 3 1 2 4 Tempatkanagarose gel pd applicator carrier  dg kutub +  dibagianatas Tempatkanapplicator ygberisi serum pd handle applicator carrier Serum 10 μl pd sumuranapplicator Tempatkanapplicator carrier pd tempatygdatar
TahapMigrasi (lanjutan) 6-16-2010 25 Tutor Imun by Nuzul Waktu 15`, 165 V, 7 ± 2 mA(set alat 60 mA)
6-16-2010 26 Text Text Text Fiksasidlm fixation sol 15` Keringkan pd 80⁰ C, 10` Pindahkan gel Tutor Imun TahapFiksasi by Nuzul
6-16-2010 27 Text Text Text Pewarnaan 4’ Destaining3x  sampaibersih Scanning Gel menghadap kebawahλ570nm Keringkan TahapStaining-DestainingTahapScanning Tutor Imun by Nuzul
Quality Control 6-16-2010 28 ,[object Object],Sebia PN 4787 / Agarose/CAPILLARYS Hypergamma Control. -liofilisat stabil, dipakai dalam jumlah kecil-kecil, dapat disimpan dalam lemari es selama kurang lebih 6 bulan Tutor Imun by Nuzul Gambar 10. Hydragel B1+B2 15/30:Normal Control Pictured 1-15Hypergamma Control Pictured 16-30
HasilPemeriksaan 6-16-2010 29 Tutor Imun by Nuzul Tabel 2. Nilai Rujukan Protein Serum ( A Manual of Laboratory and Diagnostic Test, 2000)
HasilPemeriksaan 6-16-2010 30 Tutor Imun by Nuzul Tabel 3. Nilai Rujukan Elektroforesis Protein Serum (Sheehan C,  Clinical Immunology : Principles & Laboratory Diagnosis, 1990. Roche, Reference Ranges for Adults & Chldren, 2004)
Pola NormalElektroforesis Protein Serum 6-16-2010 31 Tutor Imun by Nuzul Gambar 11. Electrophoregram normal
PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 32 Tutor Imun by Nuzul
PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 33 Tutor Imun by Nuzul Tabel 4. PolaAbnormalitasElektroforesis Protein Serum padaBerbagaiPenyakit
PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 34 Tutor Imun by Nuzul Tabel 4. Pola Abnormalitas Elektroforesis Protein Serum pada Berbagai Penyakit
Gambaran Abnormal Elektroforesis Protein Serum 6-16-2010 35 Tutor Imun by Nuzul
Gambaran Abnormal Elektroforesis Protein Serum 6-16-2010 36 Tutor Imun by Nuzul
Indikasi Elektroforesis Protein Serum 6-16-2010 37 Tutor Imun by Nuzul
6-16-2010 38 Ciri Monoclonal Gammopathy(protein M) pita tajam, batas jelas (bisa karena heavy chain, atau karena ada kappa atau lambda light chain) Ciri Polyclonal  Gammopathy pita diffuse dan lebar Tutor Imun Monoclonal GammopathyvsPolyclonal  Gammopathy by Nuzul
Electrophoregram penyakit Multiple Myeloma (dalam beberapa isotipe) 6-16-2010 39 Tutor Imun by Nuzul
Electrophoregram penyakit Multiple Myeloma (dalam beberapa isotipe) 6-16-2010 40 Tutor Imun by Nuzul
Atas perhatiannya Terima kasih ! 6-16-2010 41
Kepustakaan FW Sunderman, Jr. Recent Advances in Clinical Interpretation of Electrophoretic Fractionations of the Serum Proteins. Philadelphia : Lippincott; 1964. O’Connell Theodore X, M.D., Timothy J. Horita, M.D., Barsam Kasravi, M.D. Understanding and Interpreting Serum Protein Electrophoresis. American Family Physician. www.aafp.org/afp. January 1, 2005,Volume 71, Number 1. pp 105 – 12. Merck E. Clinical Laboratory. 11th ed. Germany; 1974. 145 - 60. _______ . A Manual of Laboratory and Diagnostic Test; 2000. Roche. Reference Ranges for Adults & Children; 2004. pp 62. Rose RN, MD et al. Manual of Clinical Laboratory Immunology. 6th ed. Washington : American Society for Microbiology Press; 2002. pp 66 – 75.  Sebia. Instruction Manual. Sebia. 2002. Sheehan C, MS, CLS, SI. Clinical Immunology : Principles and Laboratory Diagnosis. Philadelphia : J.B. Lippincott Company; 1990. pp 275 – 79.  Word KM, Lehmann CA, Leiken AM. Clinical Laboratory Instrumentation and Automation : Principles, Application and Selection.Philadelphia: WB Saunders Company; 1994. pp. 158-70. ucsdlabmed.wikidot.com/chapter – 7 – laboratory - d 6-16-2010 42
Key Term Acute-Phase Reaction - The body's response to injury of inflammation, including fever, leukocytosis, and protein changes Bence Jones protein - free light chains; An abnormal plasma or urinary protein, consisting of monoclonal immunoglobulin light chains, excreted in some neoplastic diseases and characterized by its unusual solubility properties as it precipitates on heating at 56 to 60° C and redissolves at 90 to 100° C. It is measured by immunofixation electrophoresis (IFE). MGUS - monoclonal gammopathy of undetermined significance Monoclonal immunoglobulinopathies - increased concentration of a single immunoglobin that originates from a single plasma cell clone; also known as M-proteins Paraprotein - abnormal protein appearing in large quantities as a result of a pathological process/condition: also known as myeloma components (MCs) Polyclonal hyperimmunoglobulinemias - increased concentration of immunoglobulins from many different plasma cell lines Proteinuria - Protein in the urine 6-16-2010 43
ANALYTICAL APPROACH Serum protein electrophoresis: electrophoresis is a screening test which can be followed by quantitative assay of specific proteins; independent measurement of total protein is required for conversion to absolute amounts Identify abnormalities in immunoglobulin fraction by serum immunofixation Follow specific protein abnormalities by quantitative analysis of the protein by immunoassay 6-16-2010 44
GENERAL COMMENTS ON CLINICAL ABNORMALITIES OF GAMMA-GLOBULINS Congenital Deficiency 	Immunodeficiency syndromes that are present at birth: Selective IgA deficiency, X-linked agammaglobulinemia, hyper-IgM with decreased IgG (CD40L deficiency), SCID (X-linked and autosomal) Secondary Hypogammaglobulinemias 	-Protein-losing conditions (gut, kidney) 	-Malignant lymphomas (marrow replacement and inhibition of immunoglobulin synthesis) 	-Leukemias 	-Multiple myeloma (monoclonal immunoglobulin increased while others decrease) 6-16-2010 45
GENERAL COMMENTS ON CLINICAL ABNORMALITIES OF GAMMA-GLOBULINS Polyclonal Hyperimmunoglobulinemias 	-Chronic liver disease (increase of IgA due to decreased catabolism) 	-Chronic infections (all are increased) 	-Malignancies 	-Autoimmune diseases (often IgM) 	-Miscellaneous conditions (any chronic inflammation) Monoclonal Immunoglobulinopathies (M-Proteinemia) 	-Multiple myeloma (G>A>M>E,D) 	-Primary macroglobulinemia (Waldenstrøm’s, IgM) 	-Monoclonal gammopathy of undetermined significance (MGUS) (converts at 2% per year to myeloma) 	-Miscellaneous conditions (converts at 2% per year to myeloma) 6-16-2010 46
6-16-2010 47 Example of identification of a monoclonal serum protein by immunofixation electrophoresis (Figure 1). The first track is serum protein electrophoresis (ELP). The next tracks are IgG (G), IgA (A), IgM (M), kappa light chains (K) and lambda light chains (L). The arrow indicates the position of the monoclonal protein. The second track identifies the protein as IgG after reaction with IgG antibody and protein staining. The sixth track identifies the light chain asλ.
6-16-2010 48 Example of identification of a monoclonal serum protein by immunofixation electrophoresis (Figure 2). The first track is serum protein electrophoresis (ELP). The next tracks are IgG (G), IgA (A), IgM (M), kappa light chains (K) and lambda light chains (L). The arrow indicates the position of the monoclonal protein. The third track identifies the protein as IgM after reaction with IgM antibody and protein staining. The sixth track identifies the light chain as λ.
A) Multiple myeloma Multiple myeloma is a disease of older adults characterized by bone pain that is caused by a malignancy of plasma cells. In multiple myeloma bone marrow cells become replaced by plasma cells which often produce unregulated amounts of a monoclonal antibody that can be detected in serum. On bone biopsy plasma cells >30%, 3 or more lytic lesions would define the patient as having multiple myeloma. As bone marrow is replaced, patients become anemic and eventually have bone marrow failure. The bone marrow lesions can be visualize on x-ray as characteristic “punched out lesions” which leads to bone pain, osteoporosis, pathologic fractures, and hypercalcemia. Immunofixation studies indicate that the abnormal protein is IgG in over half of the cases, one-fourth IgA, less than 10% IgM, much less than 1% IgD; and IgE is found rarely. Bence-Jones protein (kappa and lambda light chains) is present in the urine of over 50% of the patients. In about one-fourth of patients only light chains are produced by the abnormal plasma cells, and therefore monoclonal peaks may not be found in the serum since the light chains easily pass through the kidney. Hypogammaglobulinemia is often seen because immunoglobulin production by non-malignant plasma cells is also greatly reduced and catabolism is increased. 6-16-2010 49
B) Waldenstrom’smacroglobulinemia Waldenstrom’s macroglobulinemia is characterized by IgM monoclonal proteins which cause hyperviscosity of the patients serum. Typically there is an absence of lytic bone disease and no bone tenderness. The abnormal protein is of the IgM type with a molecular weight of about 1,000,000 and a sedimentation constant of 18S (Svedberg unit). Bence-Jones proteinuria occurs in about 10% of these patients. The blood may be very viscous, because these large molecules do not readily leave the plasma for the extra cellular space. The very viscous blood leads to blindness, hypertension, and priapism. 6-16-2010 50
C) Monoclonal gammopathy of undetermined significance The term “monoclonal gammopathy of undetermined significance” (MGUS) denotes the presence of an M-protein in persons without clinical evidence of multiple myeloma (MM), macroglobulinemia, primary amyloidosis (AL) or other related disorders. This occurs in 50-60% of patients presenting with M-proteins. The term “benign monoclonal gammopathy” is misleading because one does not know if the process will remain stable and benign or will develop into symptomatic MM, macroglobulinemia, or a related disorder. The frequency of monoclonal gammopathies increases with advancing age. The prevalence of MGUS is 1% of patients older than 50 years, 3% of those older than 70 years, and increases up to 10% in persons over the age of 80 years. The incidence of MGUS is higher in African-Americans and lower in elderly Japanese. MGUS is characterized by: the presence of less than 3 g/dL M-protein in serum; fewer than 10% plasma cells in the bone marrow; lack of, or only small amounts of M-protein in the urine, and a low plasma-cell labeling index (PCLI). PCLI measures the synthesis of DNA and when elevated is good evidence that the patient has MM or will soon develop it. In addition, evidence of bone lesions, anemia, hypercalcemia or renal insufficiency must be absent. Most importantly, the M-protein must remain stable and no other abnormalities develop. 6-16-2010 51
C) Monoclonal gammopathy of undetermined significance In patients recently diagnosed with MGUS, serum protein electrophoresis should be stable. The test should be repeated in 3 to 6 months. If the M-protein is constant, the test should be repeated in 6 to 12 months. If the M-protein remains constant, electrophoresis and clinical evaluation should be performed annually thereafter. Patients should be told that the actuarial risk of malignant transformation is 17% at 10 years and 33% at 20 years. The rate of development of serious disease does not differ whether the M- protein is IgG, IgA, or IgM. However, patients should also be aware that evolution from MGUS to MM can be abrupt; and therefore, they should be advised to seek medical evaluation if symptoms develop. 6-16-2010 52
6-16-2010 53
Contents 6-16-2010 54 Click to add Title Click to add Title Click to add Title Click to add Title
Contents 6-16-2010 55 2. Click to add Title 3. Click to add Title 4. Click to add Title Click to edit text styles Edit your company slogan 1. Click to add Title
Thank You ! www.themegallery.com 6-16-2010 56

Más contenido relacionado

La actualidad más candente

Fajar quality control urinalysis
Fajar quality control urinalysisFajar quality control urinalysis
Fajar quality control urinalysispdspatklinsby
 
Pemeriksaan hematologi (darah rutin)
Pemeriksaan hematologi (darah rutin)Pemeriksaan hematologi (darah rutin)
Pemeriksaan hematologi (darah rutin)Rolly Scavengers
 
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode Imunokromatografi
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode ImunokromatografiPemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode Imunokromatografi
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode ImunokromatografiPatriciaGitaNaully
 
Tpibaru7
Tpibaru7Tpibaru7
Tpibaru7andreei
 
PPT Imunologi CMIA.pptx
PPT Imunologi CMIA.pptxPPT Imunologi CMIA.pptx
PPT Imunologi CMIA.pptxIndahAipassa1
 
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptx
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptxPEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptx
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptxDikaraNovirmanPrayul
 
Pemeriksaan hemoglobin fetus (hb f)
Pemeriksaan hemoglobin fetus (hb f)Pemeriksaan hemoglobin fetus (hb f)
Pemeriksaan hemoglobin fetus (hb f)andreei
 
Praktikum imunologi by.saras
Praktikum imunologi by.sarasPraktikum imunologi by.saras
Praktikum imunologi by.sarasNheeya Warz
 
Referatbaru
ReferatbaruReferatbaru
Referatbaruandreei
 
Kinetika trombosit
Kinetika trombositKinetika trombosit
Kinetika trombositDian Jenova
 
Tibaru17
Tibaru17Tibaru17
Tibaru17andreei
 

La actualidad más candente (20)

Leukosit 2
Leukosit 2Leukosit 2
Leukosit 2
 
Fajar quality control urinalysis
Fajar quality control urinalysisFajar quality control urinalysis
Fajar quality control urinalysis
 
Pemeriksaan hematologi (darah rutin)
Pemeriksaan hematologi (darah rutin)Pemeriksaan hematologi (darah rutin)
Pemeriksaan hematologi (darah rutin)
 
Th2
Th2Th2
Th2
 
Pengertian ADT.pptx
Pengertian ADT.pptxPengertian ADT.pptx
Pengertian ADT.pptx
 
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode Imunokromatografi
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode ImunokromatografiPemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode Imunokromatografi
Pemeriksaan HBsAg, Anti-HBs, dan Anti-HCV Metode Imunokromatografi
 
Rim8
Rim8Rim8
Rim8
 
Ti16
Ti16Ti16
Ti16
 
Tpibaru7
Tpibaru7Tpibaru7
Tpibaru7
 
NEISSERIA GOORRHOEAE ppt
NEISSERIA GOORRHOEAE pptNEISSERIA GOORRHOEAE ppt
NEISSERIA GOORRHOEAE ppt
 
Th5
Th5Th5
Th5
 
PPT Imunologi CMIA.pptx
PPT Imunologi CMIA.pptxPPT Imunologi CMIA.pptx
PPT Imunologi CMIA.pptx
 
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptx
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptxPEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptx
PEMERIKSAAN HEMOGLOBIN ELEKTROFORESIS.pptx
 
Pemeriksaan hemoglobin fetus (hb f)
Pemeriksaan hemoglobin fetus (hb f)Pemeriksaan hemoglobin fetus (hb f)
Pemeriksaan hemoglobin fetus (hb f)
 
Praktikum imunologi by.saras
Praktikum imunologi by.sarasPraktikum imunologi by.saras
Praktikum imunologi by.saras
 
Sel darah merah
Sel darah merahSel darah merah
Sel darah merah
 
Referatbaru
ReferatbaruReferatbaru
Referatbaru
 
Kinetika trombosit
Kinetika trombositKinetika trombosit
Kinetika trombosit
 
Leukosit
LeukositLeukosit
Leukosit
 
Tibaru17
Tibaru17Tibaru17
Tibaru17
 

Similar a ELEKTROFORESIS PROTEIN SERUM ANALYSIS

Electrophoresis
ElectrophoresisElectrophoresis
ElectrophoresisESHA SHAH
 
2103313001_dhavalkumar H rathod_MPH101T.pptx
2103313001_dhavalkumar H rathod_MPH101T.pptx2103313001_dhavalkumar H rathod_MPH101T.pptx
2103313001_dhavalkumar H rathod_MPH101T.pptxMariyammandrawala1
 
Moving boundary electrophoresis mpat
Moving boundary electrophoresis mpatMoving boundary electrophoresis mpat
Moving boundary electrophoresis mpatHarish Rahar
 
Analytical techniques ppt
Analytical techniques pptAnalytical techniques ppt
Analytical techniques pptNikita Dewangan
 
Electrophoresis ppt.
Electrophoresis ppt.Electrophoresis ppt.
Electrophoresis ppt.gulamrafey
 
ELECTROPHORESIS.pptx
ELECTROPHORESIS.pptxELECTROPHORESIS.pptx
ELECTROPHORESIS.pptxRajesh Yadav
 
Determination of protein concentration by ultravioletspectroscopy
Determination of protein concentration by ultravioletspectroscopyDetermination of protein concentration by ultravioletspectroscopy
Determination of protein concentration by ultravioletspectroscopyHalavath Ramesh
 
Capillary electrophoresis
Capillary electrophoresisCapillary electrophoresis
Capillary electrophoresisPratik Parikh
 
4. Electrophoresis.pptx
4. Electrophoresis.pptx4. Electrophoresis.pptx
4. Electrophoresis.pptxAbelBateri1
 
Moving Boundary & Isoelctric focusing(JEEV).pptx
Moving Boundary & Isoelctric focusing(JEEV).pptxMoving Boundary & Isoelctric focusing(JEEV).pptx
Moving Boundary & Isoelctric focusing(JEEV).pptxSHREYAL7
 

Similar a ELEKTROFORESIS PROTEIN SERUM ANALYSIS (20)

Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Other electrophoresis
Other electrophoresisOther electrophoresis
Other electrophoresis
 
2103313001_dhavalkumar H rathod_MPH101T.pptx
2103313001_dhavalkumar H rathod_MPH101T.pptx2103313001_dhavalkumar H rathod_MPH101T.pptx
2103313001_dhavalkumar H rathod_MPH101T.pptx
 
Slab gel electrophoresis
Slab gel electrophoresisSlab gel electrophoresis
Slab gel electrophoresis
 
Moving boundary electrophoresis mpat
Moving boundary electrophoresis mpatMoving boundary electrophoresis mpat
Moving boundary electrophoresis mpat
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Analytical techniques ppt
Analytical techniques pptAnalytical techniques ppt
Analytical techniques ppt
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Electrophoresis ppt.
Electrophoresis ppt.Electrophoresis ppt.
Electrophoresis ppt.
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
Electrophoresis
ElectrophoresisElectrophoresis
Electrophoresis
 
ELECTROPHORESIS.pptx
ELECTROPHORESIS.pptxELECTROPHORESIS.pptx
ELECTROPHORESIS.pptx
 
Capillary electrophoresis
Capillary electrophoresisCapillary electrophoresis
Capillary electrophoresis
 
Determination of protein concentration by ultravioletspectroscopy
Determination of protein concentration by ultravioletspectroscopyDetermination of protein concentration by ultravioletspectroscopy
Determination of protein concentration by ultravioletspectroscopy
 
Biochem asgnmnt
Biochem asgnmntBiochem asgnmnt
Biochem asgnmnt
 
Capillary electrophoresis
Capillary electrophoresisCapillary electrophoresis
Capillary electrophoresis
 
4. Electrophoresis.pptx
4. Electrophoresis.pptx4. Electrophoresis.pptx
4. Electrophoresis.pptx
 
Moving Boundary & Isoelctric focusing(JEEV).pptx
Moving Boundary & Isoelctric focusing(JEEV).pptxMoving Boundary & Isoelctric focusing(JEEV).pptx
Moving Boundary & Isoelctric focusing(JEEV).pptx
 

Más de andreei

Más de andreei (20)

Tibaru18
Tibaru18Tibaru18
Tibaru18
 
Tibaru16
Tibaru16Tibaru16
Tibaru16
 
Tibaru15
Tibaru15Tibaru15
Tibaru15
 
Tibaru14
Tibaru14Tibaru14
Tibaru14
 
Tibaru13
Tibaru13Tibaru13
Tibaru13
 
Tibaru12
Tibaru12Tibaru12
Tibaru12
 
Tibaru11
Tibaru11Tibaru11
Tibaru11
 
Tibaru9
Tibaru9Tibaru9
Tibaru9
 
Tibaru11
Tibaru11Tibaru11
Tibaru11
 
Tibaru10
Tibaru10Tibaru10
Tibaru10
 
Tibaru8
Tibaru8Tibaru8
Tibaru8
 
Tibaru7
Tibaru7Tibaru7
Tibaru7
 
Refhemabaru8
Refhemabaru8Refhemabaru8
Refhemabaru8
 
Refhemabaru7
Refhemabaru7Refhemabaru7
Refhemabaru7
 
Refhemabaru6
Refhemabaru6Refhemabaru6
Refhemabaru6
 
12
1212
12
 
12
1212
12
 
11
1111
11
 
Tutor hematologi
Tutor hematologiTutor hematologi
Tutor hematologi
 
10
1010
10
 

Último

The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxThe Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxLoriGlavin3
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxLoriGlavin3
 
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxLoriGlavin3
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr BaganFwdays
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxNavinnSomaal
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfMounikaPolabathina
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersRaghuram Pandurangan
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxLoriGlavin3
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxLoriGlavin3
 
unit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxunit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxBkGupta21
 
A Deep Dive on Passkeys: FIDO Paris Seminar.pptx
A Deep Dive on Passkeys: FIDO Paris Seminar.pptxA Deep Dive on Passkeys: FIDO Paris Seminar.pptx
A Deep Dive on Passkeys: FIDO Paris Seminar.pptxLoriGlavin3
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity PlanDatabarracks
 

Último (20)

The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxThe Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
 
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptxPasskey Providers and Enabling Portability: FIDO Paris Seminar.pptx
Passkey Providers and Enabling Portability: FIDO Paris Seminar.pptx
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptx
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdf
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information Developers
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
 
unit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxunit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptx
 
A Deep Dive on Passkeys: FIDO Paris Seminar.pptx
A Deep Dive on Passkeys: FIDO Paris Seminar.pptxA Deep Dive on Passkeys: FIDO Paris Seminar.pptx
A Deep Dive on Passkeys: FIDO Paris Seminar.pptx
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity Plan
 

ELEKTROFORESIS PROTEIN SERUM ANALYSIS

  • 1. ELEKTROFORESIS PROTEIN SERUM Siswanto armadi, dr, Sp.PK(K) / Nuzulul Quriyah, drD 6-16-2010 1 Tutor Imunologi
  • 3. Elektroforesis 6-16-2010 3 Teknik pemisahan komponen/molekul bermuatan berdasarkan perbedaan tingkat migrasinya dalam sebuah medan listrik Tutor Imun by Nuzul Pergerakan pd elektroforesis dijelaskan dengan gaya Lorentz : F = qE F adalah gaya Lorentz, q adalah muatan yang dibawa oleh obyek, E adalah medan listrik Posisimolekul yang terseparasipada gel dideteksidenganpewarnaan, ataudilakukankuantifikasidengan densitometer
  • 4. Tutor Imun PrinsipElektroforesis by Nuzul Muatan listrik molekul biologi (misal : protein) tergantung pd pH dan komposisi medium dimana molekul  biologi  tersebut  terlarut bersifat amfoter yaitu bisa bermuatan positif atau negatif (bermuatan positif bila pH larutan lebih kecil daripada titik isoelektrik, bermuatan negatif bila pH larutan lebih besar daripada titik isoelektrik) Dalam suatu medan listrik, molekul  biologi  yang  bermuatan  positif  (kation) bermigrasi ke elektroda negatif (katoda) dan sebaliknya, yang bermuatan negatif (anion) bermigrasi ke elektroda positif (anoda) 6-16-2010 4
  • 5. 6-16-2010 5 Dengan elektroforesis, protein plasma dapat dipisahkan menjadi fraksi albumin serta α1, α2, β, dan γ-globulin Protein dalam plasma memiliki konsentrasi sekitar 1 mmol/L 56% protein plasma merupakan fraksi albumin, 4% adalah α1-globulin, α2-globulin 10%, β-globulin 12%, dan 18% merupakan γ-globulin Tutor Imun Protein by Nuzul
  • 7. Elektroforesis Protein 6-16-2010 Besarnya muatan Media penyangga Elektroendosmosis Suhu Ukuran molekul Kekuatan medan listrik Kekuatan ion dari bufer Kecepatan migrasi molekul Tutor Imun by Nuzul Click to add Title 7
  • 8. KomponenSistemElektroforesis 6-16-2010 8 Tutor Imun by Nuzul Power supply Sampel Bufer Media penyangga Power supply Wicks Pewarnaan Gambar 1. Komponensistemelektroforesis
  • 9. Tutor Imun by Nuzul Yang sering dipakai : serum dan plasma Cairan tubuh lain yang juga bisa dipakai : urine, cairan serebrospinal, cairan dari pleura, perikardium, peritoneum, membran sinovial, dan air mata Tidak ada persiapan khusus yang dilakukan pasien, tetapi keadaan puasa lebih baik untuk menghindari hiperlipemia Sampel yang diperlukan antara 0,3-25 μl tergantung dari konsentrasi analit dan jenis media penyangga yang digunakan Sampel diberi penanda warna untuk mengetahui kapan elektroforesis harus dihentikan, pada bufer asam dipakai methylene green atau methylene blue, sedangkan pada bufer basa dipakai bromphenol blue. SAMPEL 6-16-2010 9
  • 10. BUFER 6-16-2010 10 Tutor Imun by Nuzul Menjaga agar pH tetapkonstan Mengalirkan (conduct) arus listrik
  • 11. SyaratBufer 6-16-2010 11 1 bufer tidak boleh bereaksi dengan sampel krn interaksi antara bufer dan sampel dapat mempengaruhi gerakan molekul Tutor Imun by Nuzul 3 kekuatan ion dari larutan bufer harus dipertimbangkan kekuatan ionik rendah menghasilkan kecepatan migrasi lebih besar 2 pH yang dipilih harus memberi muatan tapi tidak menyebabkan denaturasi protein dari molekul yang diperiksa (protein dipisahkan pada suasana basa, pH 8 – 9) protein bermuatan negatif
  • 12. MEDIA PENYANGGA 6-16-2010 12 Tutor Imun by Nuzul Agarose Gel Poly- acrylamide Gel Starch Gel Cellulose Acetate Kertas murah, tapi menyerap banyak protein menghasilkan pita yang lebar, resolusinya jelek, waktu pemisahannya lebih lama granula yang mengandung amilosa dan amilopektin, bila suspensinya dilarutkan dan dipanaskan akan terbentuk larutan jernih dan menjadi gel pd pendinginan sering dipakai, bebas dari ionizable groups pada buffer basa atau netral tidak terlalu terpengaruh oleh endosmosis, resolusi lbh tajam, jernih lebih kuat daripada kertas, dg ukuran pori-pori homogen, pemisahan protein lebih cepat, absorpsi protein minimal hasil pita lebih jelas dan lebih tajam masih terbatas hanya untuk pemisahan isoenzim dari alkali fosfatase
  • 13. Endosmosis danWick Flow 6-16-2010 13 Tutor Imun by Nuzul Endosmosis (electroendosmosis)terjadiketika media penyangga jadi bermuatan negatif akibat adsorpsi ion hidroksil dari bufer muatan negatif menarik muatan positif dari bufer. Saat dialiri listrik ion positif bergerak ke arah katoda, sedang gerakan muatan negatif (misal : protein) ke arah anoda. Krn endosmosis gerakan menjadi lebih lambat, tidak bergerak atau terdorong kearah katoda Wick Flow gerakankeatasdarilarutanbufermelaluikeduatepimembran yang terendamuntukmenggantikankelembaban yang hilangakibatpemanasan. Aliraninimemperlambatgerakanmolekulpada media penyangga
  • 14. Gambar 2. Endosmosis 6-16-2010 14 Tutor Imun by Nuzul
  • 15. POWER SUPPLY 6-16-2010 15 Tutor Imun by Nuzul 0-500 volt 0-100 mA Jikaprosespemisahanbutuhwaktu lama, arus yang konstanlebihdianjurkanuntukmeminimalkankenaikansuhu Jika waktu 30 menit atau kurang, maka voltase dinaikkan
  • 16. PEWARNAAN 6-16-2010 16 Ponceau S Amido Black Oil Red O Coomassie Brilliant Blue R 250 Tutor Imun by Nuzul Schiff’s
  • 17. 6-16-2010 17 PembacaanHasil Tutor Imun by Nuzul Ada 2 Cara Kuantitatif Mengukur intensitas warna pada tiap pita. Kualitatif Membandingkan garis-garis fraksi dengan pola elektroforesis standar yang telah diketahui Metode eluasi Pita dipotong-potong beberapa bagian, pewarna kemudian dieluasikan dalam suatu larutan, warna yang larut tersebut dihitung dengan fotometer Densitometri -Intensitas warna tiap pita diukur langsung pada medianya dalam suatu sistem optik yang mirip dengan fotometer. -Jika medianya tidak transparan, maka harus dijernihkan lebih dulu
  • 18. ELEKTROFORESIS PROTEIN DI LABORATORIUM PK RSUD DR SOETOMO 6-16-2010 18
  • 19. SEBIA Hydragel Protein (E) K-20 6-16-2010 19 Tutor Imun by Nuzul Tabel 1. ReagendanBahandalam Kit Hydragel Protein (E) K20
  • 20. Alat-Alat yang Dipakai 6-16-2010 20 Tutor Imun by Nuzul Gambar 3. Electrophoresis Chamber Gambar 5. Staining - Destaining solution Gambar 4. Agarose gel
  • 21. Alat-Alat yang Dipakai 6-16-2010 21 Tutor Imun by Nuzul Gambar 6. Aplikator Gambar 7. Aplikatorcarrier Gambar 8. Microprocessor (power supply) Gambar 9. Inkubator
  • 22. Alat-Alat yang Dipakai 6-16-2010 22 Tutor Imun by Nuzul Scanner λ 570 nm atau filter kuning
  • 24. TahapMigrasi 6-16-2010 24 Tutor Imun by Nuzul 3 1 2 4 Tempatkanagarose gel pd applicator carrier dg kutub + dibagianatas Tempatkanapplicator ygberisi serum pd handle applicator carrier Serum 10 μl pd sumuranapplicator Tempatkanapplicator carrier pd tempatygdatar
  • 25. TahapMigrasi (lanjutan) 6-16-2010 25 Tutor Imun by Nuzul Waktu 15`, 165 V, 7 ± 2 mA(set alat 60 mA)
  • 26. 6-16-2010 26 Text Text Text Fiksasidlm fixation sol 15` Keringkan pd 80⁰ C, 10` Pindahkan gel Tutor Imun TahapFiksasi by Nuzul
  • 27. 6-16-2010 27 Text Text Text Pewarnaan 4’ Destaining3x sampaibersih Scanning Gel menghadap kebawahλ570nm Keringkan TahapStaining-DestainingTahapScanning Tutor Imun by Nuzul
  • 28.
  • 29. HasilPemeriksaan 6-16-2010 29 Tutor Imun by Nuzul Tabel 2. Nilai Rujukan Protein Serum ( A Manual of Laboratory and Diagnostic Test, 2000)
  • 30. HasilPemeriksaan 6-16-2010 30 Tutor Imun by Nuzul Tabel 3. Nilai Rujukan Elektroforesis Protein Serum (Sheehan C, Clinical Immunology : Principles & Laboratory Diagnosis, 1990. Roche, Reference Ranges for Adults & Chldren, 2004)
  • 31. Pola NormalElektroforesis Protein Serum 6-16-2010 31 Tutor Imun by Nuzul Gambar 11. Electrophoregram normal
  • 32. PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 32 Tutor Imun by Nuzul
  • 33. PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 33 Tutor Imun by Nuzul Tabel 4. PolaAbnormalitasElektroforesis Protein Serum padaBerbagaiPenyakit
  • 34. PolaAbnormalitasElektroforesis Protein Serum 6-16-2010 34 Tutor Imun by Nuzul Tabel 4. Pola Abnormalitas Elektroforesis Protein Serum pada Berbagai Penyakit
  • 35. Gambaran Abnormal Elektroforesis Protein Serum 6-16-2010 35 Tutor Imun by Nuzul
  • 36. Gambaran Abnormal Elektroforesis Protein Serum 6-16-2010 36 Tutor Imun by Nuzul
  • 37. Indikasi Elektroforesis Protein Serum 6-16-2010 37 Tutor Imun by Nuzul
  • 38. 6-16-2010 38 Ciri Monoclonal Gammopathy(protein M) pita tajam, batas jelas (bisa karena heavy chain, atau karena ada kappa atau lambda light chain) Ciri Polyclonal Gammopathy pita diffuse dan lebar Tutor Imun Monoclonal GammopathyvsPolyclonal Gammopathy by Nuzul
  • 39. Electrophoregram penyakit Multiple Myeloma (dalam beberapa isotipe) 6-16-2010 39 Tutor Imun by Nuzul
  • 40. Electrophoregram penyakit Multiple Myeloma (dalam beberapa isotipe) 6-16-2010 40 Tutor Imun by Nuzul
  • 41. Atas perhatiannya Terima kasih ! 6-16-2010 41
  • 42. Kepustakaan FW Sunderman, Jr. Recent Advances in Clinical Interpretation of Electrophoretic Fractionations of the Serum Proteins. Philadelphia : Lippincott; 1964. O’Connell Theodore X, M.D., Timothy J. Horita, M.D., Barsam Kasravi, M.D. Understanding and Interpreting Serum Protein Electrophoresis. American Family Physician. www.aafp.org/afp. January 1, 2005,Volume 71, Number 1. pp 105 – 12. Merck E. Clinical Laboratory. 11th ed. Germany; 1974. 145 - 60. _______ . A Manual of Laboratory and Diagnostic Test; 2000. Roche. Reference Ranges for Adults & Children; 2004. pp 62. Rose RN, MD et al. Manual of Clinical Laboratory Immunology. 6th ed. Washington : American Society for Microbiology Press; 2002. pp 66 – 75. Sebia. Instruction Manual. Sebia. 2002. Sheehan C, MS, CLS, SI. Clinical Immunology : Principles and Laboratory Diagnosis. Philadelphia : J.B. Lippincott Company; 1990. pp 275 – 79. Word KM, Lehmann CA, Leiken AM. Clinical Laboratory Instrumentation and Automation : Principles, Application and Selection.Philadelphia: WB Saunders Company; 1994. pp. 158-70. ucsdlabmed.wikidot.com/chapter – 7 – laboratory - d 6-16-2010 42
  • 43. Key Term Acute-Phase Reaction - The body's response to injury of inflammation, including fever, leukocytosis, and protein changes Bence Jones protein - free light chains; An abnormal plasma or urinary protein, consisting of monoclonal immunoglobulin light chains, excreted in some neoplastic diseases and characterized by its unusual solubility properties as it precipitates on heating at 56 to 60° C and redissolves at 90 to 100° C. It is measured by immunofixation electrophoresis (IFE). MGUS - monoclonal gammopathy of undetermined significance Monoclonal immunoglobulinopathies - increased concentration of a single immunoglobin that originates from a single plasma cell clone; also known as M-proteins Paraprotein - abnormal protein appearing in large quantities as a result of a pathological process/condition: also known as myeloma components (MCs) Polyclonal hyperimmunoglobulinemias - increased concentration of immunoglobulins from many different plasma cell lines Proteinuria - Protein in the urine 6-16-2010 43
  • 44. ANALYTICAL APPROACH Serum protein electrophoresis: electrophoresis is a screening test which can be followed by quantitative assay of specific proteins; independent measurement of total protein is required for conversion to absolute amounts Identify abnormalities in immunoglobulin fraction by serum immunofixation Follow specific protein abnormalities by quantitative analysis of the protein by immunoassay 6-16-2010 44
  • 45. GENERAL COMMENTS ON CLINICAL ABNORMALITIES OF GAMMA-GLOBULINS Congenital Deficiency Immunodeficiency syndromes that are present at birth: Selective IgA deficiency, X-linked agammaglobulinemia, hyper-IgM with decreased IgG (CD40L deficiency), SCID (X-linked and autosomal) Secondary Hypogammaglobulinemias -Protein-losing conditions (gut, kidney) -Malignant lymphomas (marrow replacement and inhibition of immunoglobulin synthesis) -Leukemias -Multiple myeloma (monoclonal immunoglobulin increased while others decrease) 6-16-2010 45
  • 46. GENERAL COMMENTS ON CLINICAL ABNORMALITIES OF GAMMA-GLOBULINS Polyclonal Hyperimmunoglobulinemias -Chronic liver disease (increase of IgA due to decreased catabolism) -Chronic infections (all are increased) -Malignancies -Autoimmune diseases (often IgM) -Miscellaneous conditions (any chronic inflammation) Monoclonal Immunoglobulinopathies (M-Proteinemia) -Multiple myeloma (G>A>M>E,D) -Primary macroglobulinemia (Waldenstrøm’s, IgM) -Monoclonal gammopathy of undetermined significance (MGUS) (converts at 2% per year to myeloma) -Miscellaneous conditions (converts at 2% per year to myeloma) 6-16-2010 46
  • 47. 6-16-2010 47 Example of identification of a monoclonal serum protein by immunofixation electrophoresis (Figure 1). The first track is serum protein electrophoresis (ELP). The next tracks are IgG (G), IgA (A), IgM (M), kappa light chains (K) and lambda light chains (L). The arrow indicates the position of the monoclonal protein. The second track identifies the protein as IgG after reaction with IgG antibody and protein staining. The sixth track identifies the light chain asλ.
  • 48. 6-16-2010 48 Example of identification of a monoclonal serum protein by immunofixation electrophoresis (Figure 2). The first track is serum protein electrophoresis (ELP). The next tracks are IgG (G), IgA (A), IgM (M), kappa light chains (K) and lambda light chains (L). The arrow indicates the position of the monoclonal protein. The third track identifies the protein as IgM after reaction with IgM antibody and protein staining. The sixth track identifies the light chain as λ.
  • 49. A) Multiple myeloma Multiple myeloma is a disease of older adults characterized by bone pain that is caused by a malignancy of plasma cells. In multiple myeloma bone marrow cells become replaced by plasma cells which often produce unregulated amounts of a monoclonal antibody that can be detected in serum. On bone biopsy plasma cells >30%, 3 or more lytic lesions would define the patient as having multiple myeloma. As bone marrow is replaced, patients become anemic and eventually have bone marrow failure. The bone marrow lesions can be visualize on x-ray as characteristic “punched out lesions” which leads to bone pain, osteoporosis, pathologic fractures, and hypercalcemia. Immunofixation studies indicate that the abnormal protein is IgG in over half of the cases, one-fourth IgA, less than 10% IgM, much less than 1% IgD; and IgE is found rarely. Bence-Jones protein (kappa and lambda light chains) is present in the urine of over 50% of the patients. In about one-fourth of patients only light chains are produced by the abnormal plasma cells, and therefore monoclonal peaks may not be found in the serum since the light chains easily pass through the kidney. Hypogammaglobulinemia is often seen because immunoglobulin production by non-malignant plasma cells is also greatly reduced and catabolism is increased. 6-16-2010 49
  • 50. B) Waldenstrom’smacroglobulinemia Waldenstrom’s macroglobulinemia is characterized by IgM monoclonal proteins which cause hyperviscosity of the patients serum. Typically there is an absence of lytic bone disease and no bone tenderness. The abnormal protein is of the IgM type with a molecular weight of about 1,000,000 and a sedimentation constant of 18S (Svedberg unit). Bence-Jones proteinuria occurs in about 10% of these patients. The blood may be very viscous, because these large molecules do not readily leave the plasma for the extra cellular space. The very viscous blood leads to blindness, hypertension, and priapism. 6-16-2010 50
  • 51. C) Monoclonal gammopathy of undetermined significance The term “monoclonal gammopathy of undetermined significance” (MGUS) denotes the presence of an M-protein in persons without clinical evidence of multiple myeloma (MM), macroglobulinemia, primary amyloidosis (AL) or other related disorders. This occurs in 50-60% of patients presenting with M-proteins. The term “benign monoclonal gammopathy” is misleading because one does not know if the process will remain stable and benign or will develop into symptomatic MM, macroglobulinemia, or a related disorder. The frequency of monoclonal gammopathies increases with advancing age. The prevalence of MGUS is 1% of patients older than 50 years, 3% of those older than 70 years, and increases up to 10% in persons over the age of 80 years. The incidence of MGUS is higher in African-Americans and lower in elderly Japanese. MGUS is characterized by: the presence of less than 3 g/dL M-protein in serum; fewer than 10% plasma cells in the bone marrow; lack of, or only small amounts of M-protein in the urine, and a low plasma-cell labeling index (PCLI). PCLI measures the synthesis of DNA and when elevated is good evidence that the patient has MM or will soon develop it. In addition, evidence of bone lesions, anemia, hypercalcemia or renal insufficiency must be absent. Most importantly, the M-protein must remain stable and no other abnormalities develop. 6-16-2010 51
  • 52. C) Monoclonal gammopathy of undetermined significance In patients recently diagnosed with MGUS, serum protein electrophoresis should be stable. The test should be repeated in 3 to 6 months. If the M-protein is constant, the test should be repeated in 6 to 12 months. If the M-protein remains constant, electrophoresis and clinical evaluation should be performed annually thereafter. Patients should be told that the actuarial risk of malignant transformation is 17% at 10 years and 33% at 20 years. The rate of development of serious disease does not differ whether the M- protein is IgG, IgA, or IgM. However, patients should also be aware that evolution from MGUS to MM can be abrupt; and therefore, they should be advised to seek medical evaluation if symptoms develop. 6-16-2010 52
  • 54. Contents 6-16-2010 54 Click to add Title Click to add Title Click to add Title Click to add Title
  • 55. Contents 6-16-2010 55 2. Click to add Title 3. Click to add Title 4. Click to add Title Click to edit text styles Edit your company slogan 1. Click to add Title
  • 56. Thank You ! www.themegallery.com 6-16-2010 56